Storia in 2 fonti

FDA draft guidance aims to reduce animal testing in cancer drug development

The FDA has issued draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.Once finalized, this would reduce the time it takes for new cancer drugs to go from discovery to patient use.

Raccontata da

healio.com

medpagetoday.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

healio.comStai leggendo2 mesi fa

FDA draft guidance aims to reduce animal testing in cancer drug development

originale

medpagetoday.com2 mesi fa

FDA Sets Sights on Animal Testing; AI Privacy Threat; Chewing Gum for Cancer?

The Oncology Institute (100 clinics, 5 states) disclosed a patient data breach; RSNA flagged new privacy risks from growing AI adoption in radiology. Both incidents confirm that clinical AI rollouts require security-by-design and HIPAA compliance from day one, not as an afterthought.

Timeline cronologica

venerdì 29 maggio 2026·healio.com
FDA draft guidance aims to reduce animal testing in cancer drug development
The FDA has issued draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.Once finalized, this would reduce the time it…
venerdì 29 maggio 2026·medpagetoday.com
FDA Sets Sights on Animal Testing; AI Privacy Threat; Chewing Gum for Cancer?
News, features, and commentary about cancer-related issues